CHM chimeric therapeutics limited

Chimeric: Media Thread, page-421

  1. 14,052 Posts.
    lightbulb Created with Sketch. 4207
    Ann 09/06/22

    Placement Shares will be priced equal to the higher of 95% of the:
    (a) average of five daily VWAPs of shares chosen by L1 Capital
    from the daily VWAPs during the Pricing Period; or
    (b) Minimum Acceptable Price, as nominated by Chimeric.


    Chimeric enters A$30 million Equity Placement Agreement with L1 Capital
    • Initial Placement of A$500,000 in ordinary shares at A$0.10 each (being the closing bid
    price yesterday, 8 June 2022) and 15,000,000 unlisted options exercisable at A$0.255
    each expiring 31 March 2024
    to be issued within seven days
    • Equity placement facility of up to a total of A$30 million over 24 months with L1 Capital,
    a leading global investment manager, by way of separate placements (the size of which
    are subject to certain limits)
    • Drawdowns under the facility are at Chimeric’s discretion and Chimeric is under no
    obligation to use the facilit


    Let's hope these oppies and the CHMOs can be exercised in 13 months. That would need the sp to be above that 25.5c.

    GLTA

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.72K 2.783M

Buyers (Bids)

No. Vol. Price($)
4 2757364 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 15260220 25
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.